NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis $2.19 -0.29 (-11.69%) (As of 09/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Intelligent Bio Solutions alerts: Email Address About Intelligent Bio Solutions Stock (NASDAQ:INBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get INBS alerts:Sign Up Key Stats Today's Range$2.05▼$2.5650-Day Range$1.07▼$2.4852-Week Range$1.00▼$16.44Volume606,347 shsAverage Volume1.77 million shsMarket Capitalization$6.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIntelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More… War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Intelligent Bio Solutions Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 11th PercentileIntelligent Bio Solutions scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Intelligent Bio Solutions.Read more about Intelligent Bio Solutions' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($3.67) to ($1.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Intelligent Bio Solutions is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Intelligent Bio Solutions is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Intelligent Bio Solutions' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.48% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 99.30%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.48% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 99.30%, indicating that investor sentiment is decreasing significantly. News and Social Media2.5 / 5News SentimentN/A News SentimentIntelligent Bio Solutions has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Intelligent Bio Solutions this week, compared to 1 article on an average week.Search Interest7 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.MarketBeat Follows2 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.28% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by InstitutionsOnly 32.97% of the stock of Intelligent Bio Solutions is held by institutions.Read more about Intelligent Bio Solutions' insider trading history. Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address INBS Stock News HeadlinesIntelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024September 11, 2024 | globenewswire.comPenny stocks analysis: AITX, Intelligent Bio (INBS), Tonix (TNXP)September 10, 2024 | msn.com⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.September 18, 2024 | Behind the Markets (Ad)What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?September 9, 2024 | msn.comIntelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-YearSeptember 9, 2024 | markets.businessinsider.comIntelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) SubmissionSeptember 5, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million EmployeesSeptember 3, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024August 21, 2024 | globenewswire.comSee More Headlines INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed this year? Intelligent Bio Solutions' stock was trading at $4.0548 at the start of the year. Since then, INBS stock has decreased by 46.0% and is now trading at $2.19. View the best growth stocks for 2024 here. When did Intelligent Bio Solutions' stock split? Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Intelligent Bio Solutions' major shareholders? Top institutional shareholders of Intelligent Bio Solutions include CVI Holdings LLC (2.56%). View institutional ownership trends. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Today9/18/2024Next Earnings (Estimated)9/19/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:INBS CUSIPN/A CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($38.91) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,630,000.00 Net Margins-354.86% Pretax Margin-356.10% Return on Equity-210.36% Return on Assets-89.33% Debt Debt-to-Equity Ratio0.01 Current Ratio2.02 Quick Ratio1.87 Sales & Book Value Annual Sales$2.83 million Price / Sales2.64 Cash FlowN/A Price / Cash FlowN/A Book Value$18.99 per share Price / Book0.13Miscellaneous Outstanding Shares3,117,000Free Float3,108,000Market Cap$7.45 million OptionableNot Optionable Beta4.68 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:INBS) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.